Flexible Pricing Mechanisms

Flexible Pricing Mechanisms: Are Payer and Manufacturer Ready? Presentation at the European Pharmaceutical Pricing and Reimbursement Meeting in London, October 6, 2015 There is major frustration on current drug pricing approaches from all stakeholders. The issues are primarily related to early access, value-for-money, affordability and equity. Historically, pricing has been based on uniform pricing schemes, … Continued

Tags: , , , , ,

Market Access Challanges for Innovate Cancer Treatments in the Nordic Region

Market Access Challenges for Innovative Cancer Treatments in the Nordic Region Reproduced from IMS’ publication: “Pharma Pricing and Reimbursement” (PPR), January 2014 At SMI’s European Pharmaceutical Pricing and Reimbursement Conference in London, in October 2013, Peter Hertzman offered his perspective on the challenges faced by manufacturers attempting to achieve access to new, innovative oncology products … Continued

Tags: , , , ,